ArticleHypertension (Dallas, Tex. : 1979)2024

Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.

Giuseppe Mancia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.